Spero Therapeutics Inc (SPRO)
1.175
-0.02
(-1.26%)
USD |
NASDAQ |
Nov 22, 16:00
1.175
0.00 (0.00%)
After-Hours: 17:58
Spero Therapeutics 1 Year Total Returns (Daily): -1.65% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | -1.65% |
November 20, 2024 | -2.44% |
November 19, 2024 | -2.52% |
November 18, 2024 | -4.20% |
November 15, 2024 | 3.51% |
November 14, 2024 | 14.68% |
November 13, 2024 | 18.02% |
November 12, 2024 | 18.92% |
November 11, 2024 | 19.82% |
November 08, 2024 | 14.78% |
November 07, 2024 | 16.96% |
November 06, 2024 | 12.93% |
November 05, 2024 | 10.08% |
November 04, 2024 | 8.40% |
November 01, 2024 | 3.51% |
October 31, 2024 | 13.89% |
October 30, 2024 | 25.24% |
October 29, 2024 | 28.43% |
October 28, 2024 | 26.47% |
October 25, 2024 | 27.88% |
October 24, 2024 | 18.87% |
October 23, 2024 | 20.00% |
October 22, 2024 | 18.69% |
October 21, 2024 | 19.63% |
October 18, 2024 | 13.27% |
Date | Value |
---|---|
October 17, 2024 | 10.78% |
October 16, 2024 | 8.77% |
October 15, 2024 | 6.19% |
October 14, 2024 | 8.85% |
October 11, 2024 | 6.84% |
October 10, 2024 | 7.83% |
October 09, 2024 | 7.83% |
October 08, 2024 | 8.77% |
October 07, 2024 | 14.04% |
October 04, 2024 | 13.04% |
October 03, 2024 | 10.26% |
October 02, 2024 | 10.08% |
October 01, 2024 | 8.26% |
September 30, 2024 | 10.74% |
September 27, 2024 | 9.17% |
September 26, 2024 | 5.79% |
September 25, 2024 | 6.67% |
September 24, 2024 | 5.79% |
September 23, 2024 | 7.44% |
September 20, 2024 | 8.13% |
September 19, 2024 | 9.27% |
September 18, 2024 | 7.20% |
September 17, 2024 | 3.91% |
September 16, 2024 | 7.03% |
September 13, 2024 | 6.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.07%
Minimum
Sep 02 2022
216.5%
Maximum
Mar 16 2021
-6.40%
Average
-4.51%
Median
1 Year Total Returns (Daily) Benchmarks
Arbutus Biopharma Corp | 89.07% |
Equillium Inc | 44.35% |
NovaBay Pharmaceuticals Inc | -93.43% |
Palatin Technologies Inc | -53.31% |
iBio Inc | -54.05% |